1. Home
  2. MPAA vs ACET Comparison

MPAA vs ACET Comparison

Compare MPAA & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$10.81

Market Cap

253.7M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$9.52

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPAA
ACET
Founded
1968
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.7M
83.3M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
MPAA
ACET
Price
$10.81
$9.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$17.50
$48.33
AVG Volume (30 Days)
109.3K
75.5K
Earning Date
06-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
162.63
N/A
EPS
N/A
N/A
Revenue
$789,806,000.00
N/A
Revenue This Year
$1.50
N/A
Revenue Next Year
$7.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.28
N/A
52 Week Low
$9.29
$0.46
52 Week High
$18.12
$9.97

Technical Indicators

Market Signals
Indicator
MPAA
ACET
Relative Strength Index (RSI) 31.51 59.98
Support Level $10.84 $7.45
Resistance Level $11.99 N/A
Average True Range (ATR) 0.40 0.51
MACD 0.04 0.05
Stochastic Oscillator 6.83 74.81

Price Performance

Historical Comparison
MPAA
ACET

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: